Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Cortes

Showing results (171-180 of 791) with videos related to

Pageof 80
Sort By:
Cancer|January 20, 2011
Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Susan O'Brien, et al.
Therapeutic Advances in Hematology|April 24, 2013
Management of imatinib-resistant patients with chronic myeloid leukemiaPavan Kumar Bhamidipati, Hagop Kantarjian, Jorge Cortes, et al.
Cancer|July 7, 2011
The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigmDon L Gibbons, Sabrina Pricl, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Progress in acute myeloid leukemiaTapan M Kadia, Farhad Ravandi, Susan O'Brien, et al.
American Journal of Cancer Research|November 17, 2025
Sex and age-related differences in one-, three-, and five-year survival for early-onset colorectal cancer in GeorgiaMeng-Han Tsai, Yue Guan, Justin X Moore, et al.
Cancer|April 25, 2003
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experienceGuillermo Lazo, Hagop Kantarjian, Elihu Estey, et al.
Psycho-Oncology|September 19, 2024
Associations Between a Social Determinant of Health Summary Measure and Self-Reported Physical and Mental Health Among Cancer SurvivorsMeng-Han Tsai, Steven S Coughlin, Minjee Lee, et al.
Current Hematologic Malignancy Reports|June 11, 2011
Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemiaMichael S Mathisen, Susan O'Brien, Deborah Thomas, et al.
Haematologica|October 9, 2002
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapyFrancis Giles, Guillermo Garcia-Manero, Jorge Cortes, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2014
Predicting outcomes in patients with chronic myeloid leukemia at any time during tyrosine kinase inhibitor therapyAlfonso Quintás-Cardama, Sangbum Choi, Hagop Kantarjian, et al.
Pageof 80

Showing results (171-180 of 791) with videos related to

Sort By:
Pageof 80
Cancer|January 20, 2011
Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Susan O'Brien, et al.
Therapeutic Advances in Hematology|April 24, 2013
Management of imatinib-resistant patients with chronic myeloid leukemiaPavan Kumar Bhamidipati, Hagop Kantarjian, Jorge Cortes, et al.
Cancer|July 7, 2011
The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigmDon L Gibbons, Sabrina Pricl, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Progress in acute myeloid leukemiaTapan M Kadia, Farhad Ravandi, Susan O'Brien, et al.
American Journal of Cancer Research|November 17, 2025
Sex and age-related differences in one-, three-, and five-year survival for early-onset colorectal cancer in GeorgiaMeng-Han Tsai, Yue Guan, Justin X Moore, et al.
Cancer|April 25, 2003
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experienceGuillermo Lazo, Hagop Kantarjian, Elihu Estey, et al.
Psycho-Oncology|September 19, 2024
Associations Between a Social Determinant of Health Summary Measure and Self-Reported Physical and Mental Health Among Cancer SurvivorsMeng-Han Tsai, Steven S Coughlin, Minjee Lee, et al.
Current Hematologic Malignancy Reports|June 11, 2011
Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemiaMichael S Mathisen, Susan O'Brien, Deborah Thomas, et al.
Haematologica|October 9, 2002
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapyFrancis Giles, Guillermo Garcia-Manero, Jorge Cortes, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2014
Predicting outcomes in patients with chronic myeloid leukemia at any time during tyrosine kinase inhibitor therapyAlfonso Quintás-Cardama, Sangbum Choi, Hagop Kantarjian, et al.
Pageof 80